Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: An 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studiesClinical Therapeutics - Tập 31 - Trang 1405-1423 - 2009
Karen A. Tourian, S. Krishna Padmanabhan, James Groark, Claudine Brisard, Deborah Farrington